These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 568805)

  • 1. Clonidine antagonizes naloxone-induced suppression of conditioned behavior and body weight loss in morphine-dependent rats.
    Sparber SB; Meyer DR
    Pharmacol Biochem Behav; 1978 Sep; 9(3):319-25. PubMed ID: 568805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
    Kosten TA
    Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats.
    Schulteis G; Stinus L; Risbrough VB; Koob GF
    Neuropsychopharmacology; 1998 Nov; 19(5):406-16. PubMed ID: 9778662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats.
    Gellert VF; Sparber SB
    J Pharmacol Exp Ther; 1977 Apr; 201(1):44-54. PubMed ID: 557543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of isobutylmethylxanthine-induced suppression of operant behavior by pretreatment of rats with clonidine.
    Kleven MS; Sparber SB
    Pharmacol Biochem Behav; 1987 Oct; 28(2):235-41. PubMed ID: 2446338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of imidazoline receptors in the anti-aversive properties of clonidine during opiate withdrawal in rats.
    Georges F; Caillé S; Vouillac C; Le Moine C; Stinus L
    Eur J Neurosci; 2005 Oct; 22(7):1812-6. PubMed ID: 16197523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist.
    Schulteis G; Chiang D; Archer C
    Pharmacol Biochem Behav; 2009 Mar; 92(1):157-63. PubMed ID: 19061911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal.
    Azar MR; Jones BC; Schulteis G
    Psychopharmacology (Berl); 2003 Oct; 170(1):42-50. PubMed ID: 12783156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine blocks and naloxone enhances suppression of operant behavior by low doses of 3-isobutyl-1-methylxanthine.
    Kleven MS; Sparber SB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):273-7. PubMed ID: 2464058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking naloxone-precipitated withdrawal in rats and hamsters.
    Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of clonidine and naloxone on schedule-controlled behavior in opioid-naive mice.
    Katz JL
    Psychopharmacology (Berl); 1989; 98(4):445-7. PubMed ID: 2505283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of lofexidine in blocking morphine-withdrawal signs in the rat.
    Shearman GT; Lal H; Ursillo RC
    Pharmacol Biochem Behav; 1980 Apr; 12(4):573-5. PubMed ID: 7190295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance and dependence after chronic administration of clonidine to the rat.
    Meyer DR; El-Azhary R; Bierer DW; Hanson SK; Robbins MS; Sparber SB
    Pharmacol Biochem Behav; 1977 Sep; 7(3):227-31. PubMed ID: 563079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
    Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
    J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonist-precipitated opioid withdrawal in rats: evidence for dissociations between physical and motivational signs.
    Higgins GA; Sellers EM
    Pharmacol Biochem Behav; 1994 May; 48(1):1-8. PubMed ID: 8029278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonidine but not nifedipine prevents the release of noradrenaline during naloxone-precipitated opiate withdrawal: an in vivo microdialysis study in the rat.
    Silverstone PH; Done C; Sharp T
    Psychopharmacology (Berl); 1992; 109(1-2):235-8. PubMed ID: 1365663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Participation of different brain regions in the anti-narcotic withdrawal action of clonidine in the dependent rat.
    Buccafusco JJ
    Brain Res; 1990 Apr; 513(1):8-14. PubMed ID: 2350687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats.
    Dwoskin LP; Neal BS; Sparber SB
    Eur J Pharmacol; 1983 Jun; 90(2-3):269-73. PubMed ID: 6683657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.